CENPE, PRC1, TTK, and PLK4 May Play Crucial Roles in the Osteosarcoma Progression

Fei Wang1, Qiheng Zhao1, Wenping Liu2

  • 1Department of Orthopedic, 74569China-Japan Union Hospital of Jilin University, Changchun, Jilin, People's Republic of China.

Insights

This study identifies key genes in osteosarcoma (OS) progression. Critical genes like CENPE, PRC1, TTK, and PLK4 were found to be potential biomarkers for OS diagnosis and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Osteosarcoma (OS) is a primary bone cancer with complex molecular underpinnings.
  • Identifying critical genes and pathways is crucial for understanding OS progression and developing targeted therapies.

Purpose of the Study:

  • To identify critical genes involved in osteosarcoma (OS) progression.
  • To elucidate the molecular mechanisms driving OS development using bioinformatics analysis.

Main Methods:

  • Analysis of differentially expressed genes (DEGs) from GSE32395 microarray data.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.
  • Construction and analysis of a protein-protein interaction (PPI) network.

Main Results:

  • 183 DEGs (100 upregulated, 83 downregulated) were identified.
  • Upregulated DEGs were enriched in "Glycosaminoglycan biosynthesis-chondroitin sulfate"; downregulated DEGs in pathways including "cell adhesion molecules" and "pentose phosphate pathway."
  • The PPI network highlighted genes CENPE, PRC1, TTK, and PLK4, potentially involved in OS development.

Conclusions:

  • The identified DEGs and enriched pathways provide insights into OS molecular mechanisms.
  • CENPE, PRC1, TTK, and PLK4 show potential as diagnostic and therapeutic biomarkers for osteosarcoma.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K